Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[haysaw]

For RCPI and its investors, there are more immediate concerns (from the March 23rd 8K):

On March 23, 2015, Rock Creek Pharmaceuticals, Inc. (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq"), notifying the Company that, for the last 30 consecutive business days, the Company has failed to comply with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum "Market Value of Listed Securities" of $35 million for continued listing on the Nasdaq Capital Market. The letter also noted that the Company did not meet the alternative requirements under Listing Rules 5550(b)(1) or 5550(b)(3).

So we have til Sept. 21st to regain compliance in this regard. As of now, Rock Creek is about $15M shy of the market value needed. If the stock goes up to $4.50 p/s or so, that would put them where they need to be. They can also do an offering and dilute -- which they will likely have to do anyway to raise capital for R&D -- but that will be detrimental to the pps.